Protalix BioTherapeutics

$3.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-3.03%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours

Why Robinhood?

You can buy or sell PLX and other stocks, options, and ETFs commission-free!

About PLX

Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel. The listed name for PLX is Protalix BioTherapeutics, Inc. Common Stock.

CEO
Dror Bashan
Employees
196
Headquarters
Karmiel, HaZafon
Founded
1993
Market Cap
128.01M
Price-Earnings Ratio
Dividend Yield
Average Volume
156.35K
High Today
$3.95
Low Today
$3.81
Open Price
$3.92
Volume
94.66K
52 Week High
$4.87
52 Week Low
$2.04

Collections

PLX Earnings

-$0.30
-$0.17
-$0.03
$0.10
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like